Biocell Pharmaceuticals

India
Pharmaceutical manufacturing and franchise services in India.

About Biocell Pharmaceuticals

Biocell Pharmaceuticals is a Healthcare company based in India. It operates as a pharmaceutical manufacturing and franchise services in India. Its Indian entity Biocell Pharmaceuticals Private Limited reported revenue of β‚Ή3.81 Cr. Biocell Pharmaceuticals offers products and services including Tablets and Capsules and Injections. Its focus areas include Pharmaceuticals, Drug Manufacturing, PCD Pharma and Franchise Distribution.

Company details

Biocell Pharmaceuticals Pvt. Ltd. is identified as a pharmaceutical company in India that has been operating since 2011, focusing on the production and supply of a wide array of medicines and healthcare products. Products such as tablets, capsules, injections, and ayurvedic items are developed to address diverse healthcare requirements, with an emphasis on innovation and quality standards. Franchise opportunities are offered through PCD Pharma, where support is provided to partners for business expansion and product distribution. Customer satisfaction is prioritized in global healthcare availability, as partnerships are facilitated with training and marketing assistance.

  • Headquarters India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Social LinkedIn X Facebook Instagram
  • Legal Name Biocell Pharmaceuticals Pvt. Ltd
  • Date of Incorporation 29 Aug, 2011
  • Jurisdiction Manimajra, Chandigarh, India
Key Metrics
  • Annual Revenue
    ₹3.81 Cr

    FY 2025 · +2% YoY

  • Net Profit
    ₹13.9 Lakh

    FY 2025 · 4% margin

  • EBITDA
    ₹22.1 Lakh

    FY 2025 · 6% margin

Products & Services of Biocell Pharmaceuticals

Biocell Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules and Injections.

Tablets and Capsules
Pharmaceutical Products

Tablets and capsules are manufactured for various healthcare applications, serving needs in treatment and prevention.

Injections
Pharmaceutical Products

Injections are supplied for medical treatments, ensuring safety and efficacy in healthcare delivery.

Board of directors of Biocell Pharmaceuticals Private Limited (Biocell Pharmaceuticals)

Biocell Pharmaceuticals Private Limited is the primary company behind Biocell Pharmaceuticals. The board of Biocell Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Anurag Bhatia, appointed in 2011. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Anurag Bhatia
DIN 02397243
Director29 Aug 201115 yrs 1 moBiocell Pharmaceuticals Private Limited
Deepika Bhatia
DIN 10961166
Director07 Feb 20251 yr 8 moBiocell Pharmaceuticals Private Limited

Financials of Biocell Pharmaceuticals

Figures of Biocell Pharmaceuticals Private Limited, the primary company behind Biocell Pharmaceuticals, for FY 2025. Revenue was ₹3.81 Cr (+2% year on year). Net profit was ₹13.9 Lakh (4% margin). EBITDA was ₹22.1 Lakh (6% margin). Revenue has grown at a compounded annual rate of +4% over three years and +8% over five years.

  • ₹3.81 CrRevenue · FY 2025 · +2% YoY
  • ₹13.9 LakhNet profit · 4% margin
  • ₹22.1 LakhEBITDA · 6% margin
  • ₹2 LakhPaid-up capital
  • +4%Revenue CAGR, 3 years
  • +8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Biocell Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Biocell Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Biocell Pharmaceuticals

Websites that share an audience with Biocell Pharmaceuticals (biocellpharma.in).

Similar websites

Websites whose visitors overlap most with Biocell Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
macrolabs.in
95%
4.4K#4,690,758View details
sanctusglobal.com
78%
1.1K#13,432,817View details
zenactspharma.com
76%
1.4K#10,654,073View details

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Biocell Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biocell Pharmaceuticals

Premium access

Complete news archive for Biocell Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biocell Pharmaceuticals

Biocell Pharmaceuticals is headquartered in India.

The primary company behind Biocell Pharmaceuticals, Biocell Pharmaceuticals Private Limited, reported revenue of β‚Ή3.81 Cr for FY 2025, up 2% year on year.

Biocell Pharmaceuticals Pvt. Ltd. is identified as a pharmaceutical company in India that has been operating since 2011, focusing on the production and supply of a wide array of medicines and healthcare products. Products such as tablets, capsules, injections, and ayurvedic items are developed to address diverse healthcare requirements, with an emphasis on innovation and quality standards. Franchise opportunities are offered through PCD Pharma, where support is provided to partners for business expansion and product distribution. Customer satisfaction is prioritized in global healthcare availability, as partnerships are facilitated with training and marketing assistance.

Biocell Pharmaceuticals offers Tablets and Capsules and Injections.

Biocell Pharmaceuticals operates through Biocell Pharmaceuticals Private Limited.

The legal entities of Biocell Pharmaceuticals currently have 2 directors, including Anurag Bhatia, Deepika Bhatia.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available